Pharmacological Inhibition of NFκB Reduces Prostate Cancer Related Osteoclastogenesis In Vitro and Osteolysis Ex Vivo.

Marino, S., Bishop, R.T., Carrasco, G. et al. (3 more authors) (2019) Pharmacological Inhibition of NFκB Reduces Prostate Cancer Related Osteoclastogenesis In Vitro and Osteolysis Ex Vivo. Calcified Tissue International. pp. 1-12. ISSN 0171-967X

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2019 The Author(s). This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Keywords: Osteolysis; NFκB; Osteoclast; Prostate cancer; Bone; Osteoclastogenesis
Dates:
  • Accepted: 20 February 2019
  • Published (online): 30 March 2019
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > Department of Oncology (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 25 Apr 2019 08:38
Last Modified: 25 Apr 2019 08:38
Status: Published online
Publisher: Springer (part of Springer Nature)
Refereed: Yes
Identification Number: https://doi.org/10.1007/s00223-019-00538-9
Related URLs:

Share / Export

Statistics